Ruikangda (Shandong) Biopharmaceutical Technology Co., Ltd. was established in 2023, headquartered in Liaocheng City, Shandong Province. The company originated from the raw material project of Shandong Ruisheng Pharmaceutical Excipients Co., Ltd. (Shandong Ruisheng Pharmaceutical Excipients Co., Ltd. was established in 2012 and is the largest and most comprehensive pharmaceutical excipient production enterprise in China). Ruikangda has the world's exclusive gene sequence with ultra-high enzyme activity. Ruikangda is the only manufacturer in the world that uses exclusive AI reasoning algorithms for gene screening, gene editing, gene expression, strain cultivation, enzyme production, and UDCA production. The company has 34 employees, including 2 PhDs and 5 masters, with an enzyme production capacity of 400 tons and a UDCA production capacity of 300 tons. It is the world's first enzyme tool to transform UDCA through AI based gene screening, and its technology and scale are globally leading. The company has independent gene synthesis technology and enzyme synthesis workshop, with international advanced level in key core areas. Our genetically engineered strains are reduced in production costs through targeted modification of multi enzyme catalytic technology; Solved the problems of high cost and long reaction steps for bear removal, enabling us to The purity and other key indicators of the product have reached a global leading level.